These Clinical Practice Guidelines (CPGs) and Clinical Practice Recommendations (CPRs) are based upon the best information available at the time of publication. They are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management.
Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health-care professional making use of these CPGs and CPRs is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol
The National Kidney Foundation makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the Work Group.
Specifically, all members of the Work Group are required to complete, sign, and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest. All affiliations are published in their entirety at the end of this publication in the Biographical Sketch section of the Work Group members.
In citing this document, the following format should be used: National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis 48:S1-S322, 2006 (suppl 1).
Support for the development of the KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Hemodialysis Adequacy 2006, Peritoneal Dialysis Adequacy 2006 and Vascular Access 2006 was provided by: Amgen, Inc., Baxter Healthcare Corporation, Fresenius USA, Inc., Genentech, Inc., and Watson Pharmaceuticals, Inc.
The National Kidney Foundation gratefully acknowledges the support of Amgen, Inc. as the founding and principal sponsor of KDOQI.